A method for estimating the probability of adverse drug reactions

Cited by (1,015)

Items 301–400 of 1,015

  1. Hair Loss After Routine Immunizations
    Robert P. Wise · 1997 · JAMA
  2. Ischemic Stroke Associated With Use of an Ephedra-Free Dietary Supplement Containing Synephrine
    Nicole C. Bouchard, Mary Ann Howland, Howard A. Greller, Robert S. Hoffman, Lewis S. Nelson · 2005 · Mayo Clinic Proceedings
  3. Cannabis and Stroke
    Daniel G. Hackam · 2015 · Stroke
  4. Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice
    Brigitte Bénard, Valérie Bastien, Benjamin Vinet · 2017 · European Respiratory Journal
  5. Update on Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management
    Hemali Shah, Rose Parisi, Eric Milan Mukherjee · 2024 · American Journal of Clinical Dermatology
  6. Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity
    Carolyn Orr, J. Eric Ahlskog · 2009 · Archives of Neurology
  7. Antipsychotic-Induced Hyponatraemia
    Didier Meulendijks, Cyndie K. Mannesse, Paul A. F. Jansen, Rob J. van Marum, Toine C. G. Egberts · 2010 · Drug Safety
  8. What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning?
    Louise W. Kao, Mark A Kirk, R. Brent Furbee, Nimish H Mehta, Jason R Skinner, Edward J. Brizendine · 2003 · Annals of Emergency Medicine
  9. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia
    Yu‐Chung Chuang, Hsin‐Yi Lin, Pao‐Yu Chen, Chi‐Ying Lin, Jann‐Tay Wang, Yee‐Chun Chen, Shan‐Chwen Chang · 2017 · Clinical Infectious Diseases
  10. Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions
    Shukla, Ajay K., Jhaj, Ratinder, Misra, Saurav, Ahmed, Shah N., Nanda, Malaya, Chaudhary, Deepa · 2021 · Journal of Family Medicine and Primary Care
  11. Effects of the Traditional Chinese Herbal Medicine Yi-Gan San for Cholinesterase Inhibitor-Resistant Visual Hallucinations and Neuropsychiatric Symptoms in Patients With Dementia With Lewy Bodies
    Koh Iwasaki, Masahiro Maruyama, Naoki Tomita, Katsutoshi Furukawa, Miyako Nemoto, Hironori Fujiwara, Takashi Seki, Masahiko Fujii, Manabu Kodama, Hiroyuki Arai · 2005 · The Journal of Clinical Psychiatry
  12. Vitamin B 12 Deficiency Associated with Histamine 2 -Receptor Antagonists and a Proton-Pump Inhibitor
    J. Mark Ruscin, Robert Lee Page II, Robert J. Valuck · 2002 · Annals of Pharmacotherapy
  13. Life-Threatening Interaction Between Complementary Medicines: Cyanide Toxicity Following Ingestion of Amygdalin and Vitamin C
    Jonathan Bromley, Brett G.M. Hughes, David CS Leong, Nicholas Allan Buckley · 2005 · Annals of Pharmacotherapy
  14. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature
    Aditya Kumar Gupta, Lynde, Lauzon · 1998 · British Journal of Dermatology
  15. Automated Surveillance for Adverse Drug Events at a Community Hospital and an Academic Medical Center
    Peter M. Kilbridge, Ursula Campbell, Heidi B. Cozart · 2006 · Journal of the American Medical Informatics Association
  16. Lamotrigine-associated anticonvulsant hypersensitivity syndrome
    Raymond G. Schlienger, Simon Robert Knowles, Neil H. Shear · 1998 · Neurology
  17. Genotype–phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations
    Yi‐Hsin Hsiao, Rosaline Chung‐Yee Hui, Tony Wu et al. · 2013 · Journal of Dermatological Science
  18. A study of adverse drug reactions in pediatric patients
    Priyadharsini Rajendran, A. Surendiran, C Adithan · 2011 · Journal of Pharmacology and Pharmacotherapeutics
  19. Do Emergency Physicians Attribute Drug-Related Emergency Department Visits to Medication-Related Problems?
    Corinne Michèle Hohl, Peter J. Zed, Jeffrey Reynold Brubacher, Riyad B. Abu‐Laban, Peter S Loewen, Roy A. Purssell · 2009 · Annals of Emergency Medicine
  20. Oral Aloe Vera-Induced Hepatitis
    Michelle M. Bottenberg, Geoffrey C. Wall, Roger L Harvey, Shahid Habib · 2007 · Annals of Pharmacotherapy
  21. Risk Factors Associated with Adverse Drug Reactions Following Hospital Admission
    Yurdaguel Zopf, Christina Rabe, Antje C. Neubert · 2008 · Drug Safety
  22. Medication‐induced SIADH: distribution and characterization according to medication class
    Daniel Shepshelovich, Amir Schechter, Bronislava Calvarysky, Talia Diker‐Cohen, Benaya Rozen‐Zvi, Anat Gafter‐Gvili · 2017 · British Journal of Clinical Pharmacology
  23. Meta‐analysis of Interventions to Reduce Adverse Drug Reactions in Older Adults
    Shelly L. Gray, Laura A. Hart, Subashan Perera, Todd P. Semla, Kenneth E. Schmader, Joseph T. Hanlon · 2017 · Journal of the American Geriatrics Society
  24. Incidence and Possible Causes of Prescribing Potentially Hazardous/Contraindicated Drug Combinations in General Practice
    Yen‐Fu Chen, Anthony John Avery, Karen E Neil, Christine Johnson, Michael E. Dewey, Ivan H. Stockley · 2005 · Drug Safety
  25. Drug‐Related Readmissions to Medical Units of Older Adults Discharged from Acute Geriatric Units: Results of the Optimization of Medication in AGE d Multicenter Randomized Controlled Trial
    Dominique Bonnet‐Zamponi, Lydie d’Arailh, Cécile Konrat · 2012 · Journal of the American Geriatrics Society
  26. Outcomes of Emergency Department Patients Presenting With Adverse Drug Events
    Corinne Michèle Hohl, Bohdan Nosyk, Lisa Kuramoto, Peter J. Zed, Jeffrey Reynold Brubacher, Riyad B. Abu‐Laban, Samuel B. Sheps, Boris G. Sobolev · 2011 · Annals of Emergency Medicine
  27. Renal Allograft Dysfunction Associated with Rifampin–Tacrolimus Interaction
    Rou-Yee Chenhsu, Che‐Chuan Loong, Mei-Huei Chou, Ming-Fang Lin, Wu–Chang Yang · 2000 · Annals of Pharmacotherapy
  28. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil
    Márcia Germana Alves de Araújo Lobo, Sandra Maria Botelho Pinheiro, José Gerley Díaz Castro · 2013 · BMC Pharmacology and Toxicology
  29. Incidence, Preventability, and Impact of Adverse Drug Events (ADEs) and Potential ADEs in Hospitalized Children in New Zealand
    Desirée L. Kunac, Julia Kennedy, Nicola C. Austin, David Martin Reith · 2009 · Pediatric Drugs
  30. Assessing Medication Appropriateness in the Elderly
    Penny S. Shelton, Michelle A. Fritsch, Mollie Ashe Scott · 2000 · Drugs & Aging
  31. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions
    Thachanan Kongpan, Surakameth Mahasirimongkol, Parinya Konyoung, Sirimas Kanjanawart, Pansu Chumworathayi, Nuanjun Wichukchinda, Runglak Kidkeukarun, Suphanlinee Preechakul, Usanee Khunarkornsiri, Warawut Bamrungram et al. · 2015 · Pharmacogenetics and Genomics
  32. Comparison of different methods for causality assessment of adverse drug reactions
    Sapan Kumar Behera, Saibal Das, Alphienes Stanley Xavier, Srinivas Velupula, Sandhiya Selvarajan · 2018 · International Journal of Clinical Pharmacy
  33. Fatal fulminant hepatic failure induced by a natural therapy containing kava
    Paul John Gow, Nathan J Connelly, Peter F Crowley, Peter Angus, Richard L Hill · 2003 · The Medical Journal of Australia
  34. Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections
    M. Montero, Juan Pablo Horcajada, Luisa Sorlí · 2009 · Infection
  35. Programmable Infusion Pumps in ICUs: An Analysis of Corresponding Adverse Drug Events
    Teryl K. Nuckols, Anthony G. Bower, Susan M. Paddock et al. · 2007 · Journal of General Internal Medicine
  36. Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis
    D Aletaha, T Kapral, J S Smolen · 2003 · Annals of the Rheumatic Diseases
  37. Cushing's Syndrome Due to Interaction Between Inhaled Corticosteroids and Itraconazole
    Mark J Bolland, Warwick Bagg, Mark G Thomas, Jennifer A Lucas, Rob Ticehurst, Peter Black · 2003 · Annals of Pharmacotherapy
  38. Hemolysis and Methemoglobinemia Secondary to Rasburicase Administration
    Linda A Browning, James A. Kruse · 2005 · Annals of Pharmacotherapy
  39. Comparison of two recently published algorithms for assessing the probability of adverse drug reactions.
    U. Busto, CAU Naranjo, Edward M. Sellers · 1982 · British Journal of Clinical Pharmacology
  40. Outcomes of Polypharmacy in Nursing Home Residents
    Bruce K. Tamura, Christina Bell, Michiko Inaba, Kamal Masaki · 2012 · Clinics in Geriatric Medicine
  41. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
    Giacomo Caldarola, Federico Pirrò, Alessandro Di Stefani et al. · 2020 · Expert Opinion on Biological Therapy
  42. Herbal hepatotoxicity: a critical review
    Rolf Teschke, Christian Frenzel, Xaver Glass · 2012 · British Journal of Clinical Pharmacology
  43. Potential Interaction between Warfarin and Boldo‐Fenugreek
    Jean‐Philippe Lambert, Julie Cormier · 2001 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  44. Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy
    Daniel M. Witt, Thomas Delate, Kathleen H. McCool et al. · 2009 · Journal of Thrombosis and Haemostasis
  45. Adverse drug reactions: a cohort study in internal medicine units at a university hospital
    Aline Lins Camargo, Maria Beatriz Cardoso Ferreira, Isabela Heineck · 2006 · European Journal of Clinical Pharmacology
  46. Acute Renal Failure After Placement of Tobramycin‐Impregnated Bone Cement in an Infected Total Knee Arthroplasty
    James M. Curtis, Vicki Sternhagen, Donald H. Batts · 2005 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  47. Cefepime Neurotoxicity: Case Report, Pharmacokinetic Considerations, and Literature Review
    Sum Lam, Irving H. Gomolin · 2006 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  48. Prescribing Optimization Method for Improving Prescribing in Elderly Patients Receiving Polypharmacy
    A. Clara Drenth‐van Maanen, Rob J. van Marum, Wilma Knol, Carolien M. J. van der Linden, Paul A. F. Jansen · 2009 · Drugs & Aging
  49. Olanzapine-Induced Glucose Dysregulation
    Tawny L Bettinger, Stacy C Mendelson, Peter G. Dorson, M. Lynn Crismon · 2000 · Annals of Pharmacotherapy
  50. Drug‐Induced Black Hairy Tongue
    Dennis Frank Thompson, Tiffany L. Kessler · 2010 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  51. Possible Interaction between Warfarin and Lycium Barbarum L.
    Annie Y. Lam, Gary W. Elmer, Michael A. Mohutsky · 2001 · Annals of Pharmacotherapy
  52. Peripheral Neuropathy Associated with Fluoroquinolones
    Jay S. Cohen · 2001 · Annals of Pharmacotherapy
  53. Safety of benznidazole use in the treatment of chronic Chagas' disease
    Alejandro Marcel Hasslocher‐Moreno, Pedro Emmanuel Alvarenga Americano do Brasil, Andréa Silvestre de Sousa, Sérgio Salles Xavier, Mayara da Costa Chambela, Gilberto Marcelo Sperandio da Silva · 2012 · Journal of Antimicrobial Chemotherapy
  54. Probable Adverse Drug Reactions in a Rural Geriatric Nursing Home Population: A Four‐Year Study
    James W. Cooper · 1996 · Journal of the American Geriatrics Society
  55. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial
    Cornelia H.M. van Jaarsveld, Johannes W. G. Jacobs, M. J. Van Der Veen, A A Blaauw, Aike Albert Kruize, Dick M. Hofman, H.L.M. Brus, G A van Albada-Kuipers, A H M Heurkens, E J ter Borg et al. · 2000 · Annals of the Rheumatic Diseases
  56. Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
    Parakkal Deepak, Derrick J. Stobaugh, Muhammed Sherid · 2013 · Alimentary Pharmacology & Therapeutics
  57. Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review.
    Francesca Renda, Paolo Mura, Gabriele Finco · 2013 · PubMed
  58. Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases
    Phantipa Sakthong, Nontapat Sonsa-ardjit, Pattarin Sukarnjanaset, Wipaporn Munpan · 2015 · Quality of Life Research
  59. Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review
    Ali Al‐Janabi, Amy Foulkes, Kayleigh J. Mason, Catherine H. Smith, Christopher E.M. Griffiths, Richard Bruce Warren · 2020 · Journal of the European Academy of Dermatology and Venereology
  60. Medical and developmental risk factors of catatonia in children and adolescents: A prospective case–control study
    Angèle Consoli, Marie Raffin, Claudine Laurent‐Levinson, Nicolas Bodeau, Dominique Campion, Zahir Amoura, Frédéric Sedel, Isabelle Gourfinkel‐An, Olivier Bonnot, David Cohen · 2012 · Schizophrenia Research
  61. Guidelines for submitting adverse event reports for publication
    William N. Kelly, Felix M Arellano, Joanne Barnes, Ulf Bergman, Ivor Ralph Edwards, Agustin Ignacio Fernández, Stephen B. Freedman, David I Goldsmith, Kui A Huang, Judith K. Jones et al. · 2007 · Pharmacoepidemiology and Drug Safety
  62. Pure Red Cell Aplasia Induced by Erythropoiesis-Stimulating Agents
    Carol A. Pollock, David Wayne Johnson, Walter H. HoCombining Diaeresisrl, Jérôme Rossert, Nicole Casadevall, Huub Schellekens, Robert Delage, Angel de Francisco, Iain C. Macdougall, Robin Thorpe et al. · 2008 · Clinical Journal of the American Society of Nephrology
  63. Evaluación de la causalidad en las comunicaciones de reacciones adversas a medicamentos. Algoritmo del Sistema Español de Farmacovigilancia
    Carmelo Aguirre, Montserrat García · 2016 · Medicina Clínica
  64. Adverse drug reactions of montelukast in children and adults
    Meindina G. Haarman, Florence P. A. M. van Hunsel, Tjalling W. de Vries · 2017 · Pharmacology Research & Perspectives
  65. Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)
    Jolien F. van Nimwegen, Esther Mossel, Greetje S. van Zuiden et al. · 2020 · The Lancet Rheumatology
  66. Regimen complexity and medication nonadherence in elderly patients
    Andrea Corsonello · 2009 · Therapeutics and Clinical Risk Management
  67. Severe irritability associated with statin cholesterol-lowering drugs
    Beatrice Alexandra Golomb, T. Kane, Joel E. Dimsdale · 2004 · QJM
  68. Hepatotoxicity Induced by Herbal and Dietary Supplements
    M. Isabel Lucena, Victor J. Navarro · 2014 · Seminars in Liver Disease
  69. SSRI-associated bruxism: A systematic review of published case reports
    A. Garrett, J. Hawley · 2018 · Neurology Clinical Practice
  70. Adverse drug event detection using natural language processing: A scoping review of supervised learning methods
    Rachel M. Murphy, Joanna Ewa Klopotowska, Nicolette F. de Keizer, Kitty J. Jager, Jan Hendrik Leopold, Dave Anton Dongelmans, Ameen Abu–Hanna, Martijn C. Schut · 2023 · PLoS ONE
  71. Self-Medication in Older Urban Mexicans
    Fernando Ruíz Balbuena, Alfredo Briones-Aranda, Albert Figueras · 2008 · Drugs & Aging
  72. The Effect of Automated Alerts on Provider Ordering Behavior in an Outpatient Setting
    Andrew Steele, Sheri L. Eisert, Joel Witter, Pat Lyons, Michael A. Jones, Patricia A. Gabow, Eduardo Ortíz · 2005 · PLoS Medicine
  73. A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: A real and separate nosological entity?
    Giulio Fortuna, Julio C. Salas‐Alanís, Guidetti Eugenio · 2011 · Journal of the American Academy of Dermatology
  74. Frequency and Preventability of Adverse Drug Reactions in Paediatric Patients
    Mary E Temple, Renee F. Robinson, Julie C. Miller · 2004 · Drug Safety
  75. Drug‐Related Hospitalizations in a Tertiary Care Internal Medicine Service of a Canadian Hospital: A Prospective Study
    Leslie Jo Samoy, Peter J. Zed, Kerry Wilbur, Robert M. Balen, Riyad B. Abu‐Laban, Mark Roberts · 2006 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  76. Second-Generation Thiazolidinediones and Hepatotoxicity
    Todd R. Marcy, Mark L. Britton, Steve M. Blevins · 2004 · Annals of Pharmacotherapy
  77. Lack of Awareness of Community-Acquired Adverse Drug Reactions Upon Hospital Admission
    Harald Dormann, Manfred Criegee‐Rieck, Antje C. Neubert · 2003 · Drug Safety
  78. Nitrous oxide analgesia for minor pediatric surgical procedures: an effective alternative to conscious sedation?
    Cathy Anne Burnweit, Jeannette Zerpa, Michel Nahmad, Charles A. Lankau, Malvin Weinberger, Leopoldo Malvezzi, Lisa Smith, Tina Shapiro, Kristine Thayer · 2004 · Journal of Pediatric Surgery
  79. Assessing methods for causality assessment of suspected adverse drug reactions
    Tom A. Hutchinson, David A. Lane · 1989 · Journal of Clinical Epidemiology
  80. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment
    Teschke, Rolf, Wolff, Albrecht, Frenzel, Christian, Schwarzenboeck, Alexander, Schulze, Johannes, Eickhoff, Axel · 2014 · World Journal of Hepatology
  81. Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib
    Romain Coriat, Stanislas Ropert, Olivier Mir · 2010 · Investigational New Drugs
  82. Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia
    Mohammed Gebre Dedefo, Abraham Haileamlak Mitike, Mulugeta Tarekegn Angamo · 2016 · BMC Pediatrics
  83. Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients
    Giovanni Genovese, Luigia Venegoni, Daniele Fanoni · 2019 · Orphanet Journal of Rare Diseases
  84. Adverse Drug Reactions in Patients with CKD
    Solène M. Laville, Valérie Gras-Champel, Julien Moragny, Marie Metzger, Christian Jacquelinet, Christian Combe, Denis P. Fouque, Maurice Laville, Luc Frimat, Bruce M. Robinson et al. · 2020 · Clinical Journal of the American Society of Nephrology
  85. The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?
    Phyllis Min-Yu Lau, Kay Stewart, Michael Joseph Dooley · 2003 · Supportive Care in Cancer
  86. Survey of Adverse Drug Reactions on a Pediatric Ward: A Strategy for Early and Detailed Detection
    Jutta Weiss, Sabine Krebs, Claudia Hoffmann · 2002 · PEDIATRICS
  87. Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors
    Linda Okafor, Peter Hewins, Philip I. Murray, Alastair Keith Denniston · 2017 · Orphanet Journal of Rare Diseases
  88. The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions
    Wei‐Ti Chen, Chuang‐Wei Wang, Chun‐Wei Lu et al. · 2018 · Journal of Investigative Dermatology
  89. Adverse Drug Events: Identification and Attribution
    Abraham G. Hartzema, Miquel S. Porta, Hugh H. Tilson · 1987 · Annals of Pharmacotherapy
  90. Lamotrighe‐Induced Severe Cutaneous Adverse Reactions
    Raymond G. Schlienger, Lori E. Shapiro, Neil H. Shear · 1998 · Epilepsia
  91. Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature.
    Amy Houghton Attaway, Tracey L. Mersfelder, Sakshi Vaishnav · 2014 · Journal of Dermatological Case Reports
  92. Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature
    Joseph William Clinton, Sara Kiparizoska, Soorya N. Aggarwal, Stephanie Mu-Lian Woo, William Davis, James H. Lewis · 2021 · Drug Safety
  93. A Pilot Pharmacokinetic and Antiangiogenic Biomarker Study of Celecoxib and Low-dose Metronomic Vinblastine or Cyclophosphamide in Pediatric Recurrent Solid Tumors
    Diana Stempak, Janet Gammon, Jacqueline Halton · 2006 · Journal of Pediatric Hematology/Oncology
  94. Drug-induced uveitis
    Nikolas J. S. London, Sunir J. Garg, Ramana S. Moorthy, Emmett T. Cunningham · 2013 · Journal of Ophthalmic Inflammation and Infection
  95. Possible Anaphylaxis after Propofol in a Child with Food Allergy
    Kristi N Hofer, M. McCarthy, M. Buck, A. Hendrick · 2003 · The Annals of Pharmacotherapy
  96. Acute renal failure after antibiotic-impregnated bone cement treatment of an infected total knee arthroplasty
    S. Dovas, Vassilios Liakopoulos, Loukia K. Papatheodorou, I Chronopoulou, V.A. Papavasiliou, E Atmatzidis, M. Giannopoulou, Theodoros Eleftheriadis, Theodora Simopoulou, Theofilos S. Karachalios et al. · 2008 · Clinical Nephrology
  97. The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
    Gianluca Trifirò, Rosa Gini, Francesco Barone‐Adesi, Ettore Beghi, Anna Cantarutti, Annalisa Capuano, Carla Carnovale, Antonio Clavenna, Mirosa Dellagiovanna, Carmen Ferrajolo et al. · 2018 · Drug Safety
  98. Reacciones adversas a medicamentos
    Eva Montané, Javier Santesmases · 2019 · Medicina Clínica
  99. Drugs and the skin: A concise review of cutaneous adverse drug reactions
    Blanca R. Del Pozzo‐Magaña, Carmen Liy‐Wong · 2022 · British Journal of Clinical Pharmacology
  100. Adverse drug reactions in hospital in-patients: a pilot study
    Emma C. Davies, C. F. Green, David R. Mottram · 2006 · Journal of Clinical Pharmacy and Therapeutics